Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice - PubMed (original) (raw)
. 2002 Nov 14;21(52):7945-56.
doi: 10.1038/sj.onc.1205956.
Affiliations
- PMID: 12439745
- DOI: 10.1038/sj.onc.1205956
Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice
Thomas Hawighorst et al. Oncogene. 2002.
Abstract
The roles played by the endogenous angiogenesis inhibitor thrombospondin-1 (TSP-1) in the early stages of multi-step carcinogenesis and in the control of hematogenous versus lymphatic metastasis are unknown. To investigate these issues we compared tumor development in normal mice and in transgenic mice with targeted overexpression of TSP-1 in the epidermis following a standard two-step chemical skin carcinogenesis regimen. Overexpression of TSP-1 resulted in delayed and reduced development of premalignant epithelial hyperplasias, but did not inhibit the malignant conversion to squamous cell carcinomas. TSP-1 overexpression also suppressed tumor angiogenesis and distant organ metastasis, but failed to inhibit tumor-associated lymphangiogenesis or lymphatic tumor spread to regional lymph nodes. Concomitant with these results, we found that the endothelial TSP-1 receptor CD36 was mostly absent from cutaneous lymphatic vessels. Our findings indicate the potential use of TSP-1 for the prevention of premalignant stages of tumorigenesis and are likely to have implications for the further development of anti-angiogenic cancer therapies.
Similar articles
- Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.
Brideau G, Mäkinen MJ, Elamaa H, Tu H, Nilsson G, Alitalo K, Pihlajaniemi T, Heljasvaara R. Brideau G, et al. Cancer Res. 2007 Dec 15;67(24):11528-35. doi: 10.1158/0008-5472.CAN-07-1458. Cancer Res. 2007. PMID: 18089781 - [Angiogenesis, lymphangiogenesis, and tumor progression].
Hawighorst T. Hawighorst T. Zentralbl Gynakol. 2002 Nov;124(11):497-505. doi: 10.1055/s-2002-39653. Zentralbl Gynakol. 2002. PMID: 12796842 Review. German. - The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B, Arendt S, Muffler S, Steinkraus V, Bröcker EB, Birek C, Hartschuh W, Jauch A, Boukamp P. Burnworth B, et al. Eur J Cell Biol. 2007 Dec;86(11-12):763-80. doi: 10.1016/j.ejcb.2006.11.002. Epub 2007 Jan 2. Eur J Cell Biol. 2007. PMID: 17198740 - p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Ruddell A, Kelly-Spratt KS, Furuya M, Parghi SS, Kemp CJ. Ruddell A, et al. Oncogene. 2008 May 15;27(22):3145-55. doi: 10.1038/sj.onc.1210973. Epub 2007 Dec 3. Oncogene. 2008. PMID: 18059331 - Molecular control of lymphatic metastasis.
Achen MG, Stacker SA. Achen MG, et al. Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review.
Cited by
- Molecular regulation of tumor angiogenesis and perfusion via redox signaling.
Miller TW, Isenberg JS, Roberts DD. Miller TW, et al. Chem Rev. 2009 Jul;109(7):3099-124. doi: 10.1021/cr8005125. Chem Rev. 2009. PMID: 19374334 Free PMC article. Review. No abstract available. - PEDF inhibits lymphatic metastasis of nasopharyngeal carcinoma as a new lymphangiogenesis inhibitor.
Luo C, Yin H, Gao T, Ma C, Liu J, Zhang T, Xu Z, Wang X, Zhang D, Qi W, Yang Z, Gao G, Yang X, Zhou T. Luo C, et al. Cell Death Dis. 2021 Mar 17;12(4):295. doi: 10.1038/s41419-021-03583-1. Cell Death Dis. 2021. PMID: 33731707 Free PMC article. - VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.
Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. Hirakawa S, et al. J Exp Med. 2005 Apr 4;201(7):1089-99. doi: 10.1084/jem.20041896. J Exp Med. 2005. PMID: 15809353 Free PMC article. - Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells.
Cifarelli V, Appak-Baskoy S, Peche VS, Kluzak A, Shew T, Narendran R, Pietka KM, Cella M, Walls CW, Czepielewski R, Ivanov S, Randolph GJ, Augustin HG, Abumrad NA. Cifarelli V, et al. Nat Commun. 2021 Jun 7;12(1):3350. doi: 10.1038/s41467-021-23808-3. Nat Commun. 2021. PMID: 34099721 Free PMC article. - The formation of lymphatic vessels and its importance in the setting of malignancy.
Detmar M, Hirakawa S. Detmar M, et al. J Exp Med. 2002 Sep 16;196(6):713-8. doi: 10.1084/jem.20021346. J Exp Med. 2002. PMID: 12235205 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
- CA69184/CA/NCI NIH HHS/United States
- CA86410/CA/NCI NIH HHS/United States
- CA91861/CA/NCI NIH HHS/United States
- EY12162/EY/NEI NIH HHS/United States
- GM58462/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous